Generate Biomedicines, Inc. (GENB)

20.90 +3.18 (+17.95%) USD  |  NASDAQ  |  Aug 25, 11:13
More

Generate Biomedicines EPS Estimates for Next Fiscal Year

EPS Estimates for Next Fiscal Year Chart

View EPS Estimates for Next Fiscal Year for GENB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for Next Fiscal Year Chart
Start Trial

Historical EPS Estimates for Next Fiscal Year Data

View and export this data back to 2026. Start Trial.
Date Value
August 17, 2026 --
August 06, 2026 --
May 14, 2026 --
Date Value
May 08, 2026 --
May 07, 2026 --
March 24, 2026 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Next Fiscal Year Range, Past 5 Years

View EPS Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Next Fiscal Year Benchmarks

View EPS Estimates for Next Fiscal Year Benchmarks
Start Trial
Twist Bioscience Corp. Upgrade
Prime Medicine, Inc. Upgrade
Intellia Therapeutics, Inc. Upgrade
Beam Therapeutics, Inc. Upgrade
Moderna, Inc. Upgrade

EPS Estimates for Next Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade